Mariner’s Sutro Biopharma STRO Stock Holding History

Mariner’s Portfolio STRO Stock Details STRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,363	Closed	-$9.73K	–	3754
2025 Q2	$9.73K	Buy	+1,363	New	+$11.1K	﹤0.01%	3451

Other funds holding STRO

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Mariner's STRO Position: Q3 2025 in Review

Mariner sold out of Sutro Biopharma (STRO) in Q3 2025, closing a stake of 1,363 shares — an estimated $9.73K sold.

Mariner first reported a position in STRO in Q2 2025 and held it in 1 quarter. The position peaked at $9.73K in Q2 2025. 87 funds tracked by Wall St. Rank hold STRO as of Q3 2025.

Mariner reported no remaining Sutro Biopharma position as of Q3 2025 after selling out during the quarter.
Mariner sold 1,363 Sutro Biopharma shares in Q3 2025, an estimated $9.73K.
Mariner first reported a position in Sutro Biopharma in Q2 2025 and held it in 1 quarter.
Mariner's Sutro Biopharma position peaked at $9.73K in Q2 2025.
87 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2025.

Based on Mariner's 13F filing for Q3 2025, filed 14 Nov 2025.